Status:
COMPLETED
Evaluation of Atacand® (Candesartan) in Daily Medical Practice
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This open label, non-interventional study is to show the efficacy of antihypertensive treatment with Atacand in hypertensive patients. Efficacy is to be evaluated based on the difference in systolic a...
Eligibility Criteria
Inclusion
- a patient with arterial hypertension who has been prescribed Atacand according to physician's judgement, irrespective of the inclusion in the study
Exclusion
- hypersensitivity to candesartan or any other ingredient of Atacand
- liver function impairment and/or cholestasis
- severe renal insufficiency
- woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00837720
Start Date
March 1 2006
End Date
June 1 2007
Last Update
February 6 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.